nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloramphenicol—CYP3A4—Fingolimod—multiple sclerosis	0.0694	0.106	CbGbCtD
Chloramphenicol—CYP3A7—Dexamethasone—multiple sclerosis	0.0578	0.0884	CbGbCtD
Chloramphenicol—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0578	0.0884	CbGbCtD
Chloramphenicol—CYP2C19—Prednisone—multiple sclerosis	0.056	0.0857	CbGbCtD
Chloramphenicol—SLC22A6—Methotrexate—multiple sclerosis	0.0509	0.0778	CbGbCtD
Chloramphenicol—CYP3A4—Methylprednisolone—multiple sclerosis	0.0447	0.0684	CbGbCtD
Chloramphenicol—CYP3A5—Dexamethasone—multiple sclerosis	0.0434	0.0663	CbGbCtD
Chloramphenicol—CYP2C8—Dexamethasone—multiple sclerosis	0.0417	0.0638	CbGbCtD
Chloramphenicol—CYP2C19—Dexamethasone—multiple sclerosis	0.035	0.0535	CbGbCtD
Chloramphenicol—CYP3A4—Triamcinolone—multiple sclerosis	0.0339	0.0518	CbGbCtD
Chloramphenicol—CYP3A4—Mitoxantrone—multiple sclerosis	0.0326	0.0499	CbGbCtD
Chloramphenicol—CYP2C9—Dexamethasone—multiple sclerosis	0.0291	0.0445	CbGbCtD
Chloramphenicol—CYP3A4—Betamethasone—multiple sclerosis	0.0291	0.0445	CbGbCtD
Chloramphenicol—CYP3A4—Prednisolone—multiple sclerosis	0.0287	0.0439	CbGbCtD
Chloramphenicol—CYP3A4—Prednisone—multiple sclerosis	0.0271	0.0414	CbGbCtD
Chloramphenicol—CYP3A4—Dexamethasone—multiple sclerosis	0.0169	0.0259	CbGbCtD
Chloramphenicol—Reaction gastrointestinal—Azathioprine—multiple sclerosis	0.00722	0.0368	CcSEcCtD
Chloramphenicol—Neuritis—Cladribine—multiple sclerosis	0.00397	0.0202	CcSEcCtD
Chloramphenicol—Conjunctival hyperaemia—Prednisolone—multiple sclerosis	0.00363	0.0185	CcSEcCtD
Chloramphenicol—Leukaemia—Methotrexate—multiple sclerosis	0.0036	0.0184	CcSEcCtD
Chloramphenicol—Bone marrow depression—Azathioprine—multiple sclerosis	0.00357	0.0182	CcSEcCtD
Chloramphenicol—Blood disorder—Cladribine—multiple sclerosis	0.00355	0.0181	CcSEcCtD
Chloramphenicol—Conjunctival hyperaemia—Dexamethasone—multiple sclerosis	0.00303	0.0154	CcSEcCtD
Chloramphenicol—Conjunctival hyperaemia—Betamethasone—multiple sclerosis	0.00303	0.0154	CcSEcCtD
Chloramphenicol—Reaction gastrointestinal—Methotrexate—multiple sclerosis	0.00291	0.0148	CcSEcCtD
Chloramphenicol—Bone marrow depression—Mitoxantrone—multiple sclerosis	0.00288	0.0147	CcSEcCtD
Chloramphenicol—Endophthalmitis—Betamethasone—multiple sclerosis	0.0028	0.0143	CcSEcCtD
Chloramphenicol—Endophthalmitis—Dexamethasone—multiple sclerosis	0.0028	0.0143	CcSEcCtD
Chloramphenicol—Aplastic anaemia—Cladribine—multiple sclerosis	0.00278	0.0142	CcSEcCtD
Chloramphenicol—Eye disorder—Fingolimod—multiple sclerosis	0.00245	0.0125	CcSEcCtD
Chloramphenicol—Endophthalmitis—Prednisone—multiple sclerosis	0.00244	0.0124	CcSEcCtD
Chloramphenicol—Aplastic anaemia—Azathioprine—multiple sclerosis	0.00226	0.0115	CcSEcCtD
Chloramphenicol—Neuritis—Prednisolone—multiple sclerosis	0.00214	0.0109	CcSEcCtD
Chloramphenicol—Leukopenia—Fingolimod—multiple sclerosis	0.00204	0.0104	CcSEcCtD
Chloramphenicol—Stinging—Prednisolone—multiple sclerosis	0.00197	0.01	CcSEcCtD
Chloramphenicol—Neuritis—Triamcinolone—multiple sclerosis	0.00197	0.01	CcSEcCtD
Chloramphenicol—Neuritis—Methylprednisolone—multiple sclerosis	0.00196	0.01	CcSEcCtD
Chloramphenicol—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00193	0.00984	CcSEcCtD
Chloramphenicol—Eye irritation—Prednisolone—multiple sclerosis	0.00187	0.00953	CcSEcCtD
Chloramphenicol—Nervous system disorder—Fingolimod—multiple sclerosis	0.00183	0.00932	CcSEcCtD
Chloramphenicol—Stinging—Triamcinolone—multiple sclerosis	0.00181	0.00924	CcSEcCtD
Chloramphenicol—Skin disorder—Fingolimod—multiple sclerosis	0.00181	0.00923	CcSEcCtD
Chloramphenicol—Neuritis—Betamethasone—multiple sclerosis	0.00179	0.0091	CcSEcCtD
Chloramphenicol—Neuritis—Dexamethasone—multiple sclerosis	0.00179	0.0091	CcSEcCtD
Chloramphenicol—Pancytopenia—Cladribine—multiple sclerosis	0.00176	0.009	CcSEcCtD
Chloramphenicol—Stinging—Betamethasone—multiple sclerosis	0.00165	0.00839	CcSEcCtD
Chloramphenicol—Stinging—Dexamethasone—multiple sclerosis	0.00165	0.00839	CcSEcCtD
Chloramphenicol—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00161	0.0082	CcSEcCtD
Chloramphenicol—Neuritis—Prednisone—multiple sclerosis	0.00155	0.00792	CcSEcCtD
Chloramphenicol—Bone marrow depression—Methotrexate—multiple sclerosis	0.00144	0.00732	CcSEcCtD
Chloramphenicol—Pancytopenia—Azathioprine—multiple sclerosis	0.00144	0.00731	CcSEcCtD
Chloramphenicol—Burning sensation—Methotrexate—multiple sclerosis	0.0014	0.00712	CcSEcCtD
Chloramphenicol—Eye disorder—Cladribine—multiple sclerosis	0.00139	0.00709	CcSEcCtD
Chloramphenicol—Cyanosis—Methotrexate—multiple sclerosis	0.00137	0.00699	CcSEcCtD
Chloramphenicol—Delirium—Prednisone—multiple sclerosis	0.00135	0.00688	CcSEcCtD
Chloramphenicol—Immune system disorder—Cladribine—multiple sclerosis	0.00134	0.00685	CcSEcCtD
Chloramphenicol—Pruritus—Fingolimod—multiple sclerosis	0.00132	0.00672	CcSEcCtD
Chloramphenicol—Diarrhoea—Fingolimod—multiple sclerosis	0.00128	0.0065	CcSEcCtD
Chloramphenicol—Agranulocytosis—Azathioprine—multiple sclerosis	0.00126	0.00641	CcSEcCtD
Chloramphenicol—Headache—Fingolimod—multiple sclerosis	0.00117	0.00595	CcSEcCtD
Chloramphenicol—Pancytopenia—Mitoxantrone—multiple sclerosis	0.00116	0.00591	CcSEcCtD
Chloramphenicol—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00109	0.00558	CcSEcCtD
Chloramphenicol—Immune system disorder—Azathioprine—multiple sclerosis	0.00109	0.00557	CcSEcCtD
Chloramphenicol—Confusional state—Cladribine—multiple sclerosis	0.00107	0.00543	CcSEcCtD
Chloramphenicol—Stomatitis—Mitoxantrone—multiple sclerosis	0.00106	0.00541	CcSEcCtD
Chloramphenicol—Glossitis—Methotrexate—multiple sclerosis	0.00105	0.00537	CcSEcCtD
Chloramphenicol—Nervous system disorder—Cladribine—multiple sclerosis	0.00104	0.00528	CcSEcCtD
Chloramphenicol—Thrombocytopenia—Cladribine—multiple sclerosis	0.00103	0.00527	CcSEcCtD
Chloramphenicol—Skin disorder—Cladribine—multiple sclerosis	0.00103	0.00523	CcSEcCtD
Chloramphenicol—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00102	0.00518	CcSEcCtD
Chloramphenicol—Abdominal distension—Prednisolone—multiple sclerosis	0.00101	0.00514	CcSEcCtD
Chloramphenicol—Leukopenia—Azathioprine—multiple sclerosis	0.000942	0.0048	CcSEcCtD
Chloramphenicol—Abdominal distension—Triamcinolone—multiple sclerosis	0.000928	0.00473	CcSEcCtD
Chloramphenicol—Abdominal distension—Methylprednisolone—multiple sclerosis	0.000926	0.00472	CcSEcCtD
Chloramphenicol—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000912	0.00465	CcSEcCtD
Chloramphenicol—Aplastic anaemia—Methotrexate—multiple sclerosis	0.000911	0.00464	CcSEcCtD
Chloramphenicol—Pain—Cladribine—multiple sclerosis	0.000904	0.00461	CcSEcCtD
Chloramphenicol—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00089	0.00454	CcSEcCtD
Chloramphenicol—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.000876	0.00446	CcSEcCtD
Chloramphenicol—Feeling abnormal—Cladribine—multiple sclerosis	0.000871	0.00444	CcSEcCtD
Chloramphenicol—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000841	0.00429	CcSEcCtD
Chloramphenicol—Urticaria—Cladribine—multiple sclerosis	0.00084	0.00428	CcSEcCtD
Chloramphenicol—Body temperature increased—Cladribine—multiple sclerosis	0.000835	0.00426	CcSEcCtD
Chloramphenicol—Skin disorder—Azathioprine—multiple sclerosis	0.000835	0.00425	CcSEcCtD
Chloramphenicol—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.000805	0.00411	CcSEcCtD
Chloramphenicol—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000804	0.0041	CcSEcCtD
Chloramphenicol—Hypersensitivity—Cladribine—multiple sclerosis	0.000779	0.00397	CcSEcCtD
Chloramphenicol—Leukopenia—Mitoxantrone—multiple sclerosis	0.000762	0.00388	CcSEcCtD
Chloramphenicol—Pruritus—Cladribine—multiple sclerosis	0.000748	0.00381	CcSEcCtD
Chloramphenicol—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000742	0.00378	CcSEcCtD
Chloramphenicol—Abdominal distension—Prednisone—multiple sclerosis	0.000733	0.00374	CcSEcCtD
Chloramphenicol—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000731	0.00373	CcSEcCtD
Chloramphenicol—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000731	0.00373	CcSEcCtD
Chloramphenicol—Diarrhoea—Cladribine—multiple sclerosis	0.000723	0.00369	CcSEcCtD
Chloramphenicol—Feeling abnormal—Azathioprine—multiple sclerosis	0.000708	0.00361	CcSEcCtD
Chloramphenicol—Confusional state—Mitoxantrone—multiple sclerosis	0.0007	0.00357	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000695	0.00354	CcSEcCtD
Chloramphenicol—Eye disorder—Methylprednisolone—multiple sclerosis	0.000688	0.00351	CcSEcCtD
Chloramphenicol—Shock—Mitoxantrone—multiple sclerosis	0.000683	0.00348	CcSEcCtD
Chloramphenicol—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00068	0.00347	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—TNFAIP3—multiple sclerosis	0.000679	0.00454	CbGpPWpGaD
Chloramphenicol—Body temperature increased—Azathioprine—multiple sclerosis	0.000679	0.00346	CcSEcCtD
Chloramphenicol—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000675	0.00451	CbGpPWpGaD
Chloramphenicol—Skin disorder—Mitoxantrone—multiple sclerosis	0.000675	0.00344	CcSEcCtD
Chloramphenicol—Vomiting—Cladribine—multiple sclerosis	0.000672	0.00342	CcSEcCtD
Chloramphenicol—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000669	0.00447	CbGpPWpGaD
Chloramphenicol—Rash—Cladribine—multiple sclerosis	0.000666	0.0034	CcSEcCtD
Chloramphenicol—Dermatitis—Cladribine—multiple sclerosis	0.000666	0.00339	CcSEcCtD
Chloramphenicol—CD55—Immune System—IL7—multiple sclerosis	0.000665	0.00444	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—C4A—multiple sclerosis	0.000665	0.00444	CbGpPWpGaD
Chloramphenicol—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000665	0.00339	CcSEcCtD
Chloramphenicol—Headache—Cladribine—multiple sclerosis	0.000662	0.00337	CcSEcCtD
Chloramphenicol—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000653	0.00436	CbGpPWpGaD
Chloramphenicol—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000653	0.00436	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—GPR65—multiple sclerosis	0.000649	0.00433	CbGpPWpGaD
Chloramphenicol—Angioedema—Prednisolone—multiple sclerosis	0.000638	0.00325	CcSEcCtD
Chloramphenicol—CD55—Immune System—PDCD1—multiple sclerosis	0.000638	0.00426	CbGpPWpGaD
Chloramphenicol—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000636	0.00324	CcSEcCtD
Chloramphenicol—Hypersensitivity—Azathioprine—multiple sclerosis	0.000633	0.00323	CcSEcCtD
Chloramphenicol—Nausea—Cladribine—multiple sclerosis	0.000628	0.0032	CcSEcCtD
Chloramphenicol—CD55—Signaling Pathways—LINGO1—multiple sclerosis	0.000628	0.00419	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—IL7R—multiple sclerosis	0.000626	0.00418	CbGpPWpGaD
Chloramphenicol—Eye disorder—Betamethasone—multiple sclerosis	0.000626	0.00319	CcSEcCtD
Chloramphenicol—Eye disorder—Dexamethasone—multiple sclerosis	0.000626	0.00319	CcSEcCtD
Chloramphenicol—CYP3A7—Biological oxidations—CYP24A1—multiple sclerosis	0.00062	0.00414	CbGpPWpGaD
Chloramphenicol—CYP3A7—Biological oxidations—CYP27B1—multiple sclerosis	0.00062	0.00414	CbGpPWpGaD
Chloramphenicol—CD55—GPCR ligand binding—CXCL10—multiple sclerosis	0.000619	0.00413	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000612	0.00408	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000612	0.00408	CbGpPWpGaD
Chloramphenicol—CD55—Innate Immune System—CD28—multiple sclerosis	0.000611	0.00408	CbGpPWpGaD
Chloramphenicol—CD55—Innate Immune System—CCR2—multiple sclerosis	0.0006	0.00401	CbGpPWpGaD
Chloramphenicol—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000595	0.00397	CbGpPWpGaD
Chloramphenicol—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000595	0.00397	CbGpPWpGaD
Chloramphenicol—Pain—Mitoxantrone—multiple sclerosis	0.000594	0.00303	CcSEcCtD
Chloramphenicol—CD55—Signaling by GPCR—CXCL13—multiple sclerosis	0.000594	0.00396	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—CCR1—multiple sclerosis	0.000594	0.00396	CbGpPWpGaD
Chloramphenicol—Diarrhoea—Azathioprine—multiple sclerosis	0.000588	0.003	CcSEcCtD
Chloramphenicol—Angioedema—Triamcinolone—multiple sclerosis	0.000587	0.00299	CcSEcCtD
Chloramphenicol—Angioedema—Methylprednisolone—multiple sclerosis	0.000585	0.00298	CcSEcCtD
Chloramphenicol—Pancytopenia—Methotrexate—multiple sclerosis	0.000578	0.00295	CcSEcCtD
Chloramphenicol—CD55—Immune System—CBLB—multiple sclerosis	0.000574	0.00383	CbGpPWpGaD
Chloramphenicol—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000574	0.00383	CbGpPWpGaD
Chloramphenicol—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000572	0.00292	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00057	0.0029	CcSEcCtD
Chloramphenicol—Shock—Prednisolone—multiple sclerosis	0.000561	0.00286	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—IFNB1—multiple sclerosis	0.000554	0.0037	CbGpPWpGaD
Chloramphenicol—Urticaria—Mitoxantrone—multiple sclerosis	0.000552	0.00281	CcSEcCtD
Chloramphenicol—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000549	0.0028	CcSEcCtD
Chloramphenicol—Vomiting—Azathioprine—multiple sclerosis	0.000546	0.00278	CcSEcCtD
Chloramphenicol—Eye disorder—Prednisone—multiple sclerosis	0.000545	0.00278	CcSEcCtD
Chloramphenicol—CD55—Signaling Pathways—TAGAP—multiple sclerosis	0.000544	0.00363	CbGpPWpGaD
Chloramphenicol—Rash—Azathioprine—multiple sclerosis	0.000542	0.00276	CcSEcCtD
Chloramphenicol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000542	0.00276	CcSEcCtD
Chloramphenicol—Dermatitis—Azathioprine—multiple sclerosis	0.000541	0.00276	CcSEcCtD
Chloramphenicol—Headache—Azathioprine—multiple sclerosis	0.000538	0.00274	CcSEcCtD
Chloramphenicol—CD55—GPCR ligand binding—CCL5—multiple sclerosis	0.000533	0.00356	CbGpPWpGaD
Chloramphenicol—Angioedema—Betamethasone—multiple sclerosis	0.000532	0.00271	CcSEcCtD
Chloramphenicol—Angioedema—Dexamethasone—multiple sclerosis	0.000532	0.00271	CcSEcCtD
Chloramphenicol—Stomatitis—Methotrexate—multiple sclerosis	0.000529	0.0027	CcSEcCtD
Chloramphenicol—Confusional state—Methylprednisolone—multiple sclerosis	0.000527	0.00269	CcSEcCtD
Chloramphenicol—Immune system disorder—Prednisone—multiple sclerosis	0.000526	0.00268	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000524	0.00267	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000523	0.00267	CcSEcCtD
Chloramphenicol—Shock—Triamcinolone—multiple sclerosis	0.000516	0.00263	CcSEcCtD
Chloramphenicol—Shock—Methylprednisolone—multiple sclerosis	0.000514	0.00262	CcSEcCtD
Chloramphenicol—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000513	0.00261	CcSEcCtD
Chloramphenicol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000512	0.00261	CcSEcCtD
Chloramphenicol—Nausea—Azathioprine—multiple sclerosis	0.00051	0.0026	CcSEcCtD
Chloramphenicol—CD55—Immune System—MX1—multiple sclerosis	0.00051	0.0034	CbGpPWpGaD
Chloramphenicol—Skin disorder—Methylprednisolone—multiple sclerosis	0.000508	0.00259	CcSEcCtD
Chloramphenicol—Agranulocytosis—Methotrexate—multiple sclerosis	0.000506	0.00258	CcSEcCtD
Chloramphenicol—CD55—Immune System—HLA-DRA—multiple sclerosis	0.000493	0.00329	CbGpPWpGaD
Chloramphenicol—Pain—Prednisolone—multiple sclerosis	0.000487	0.00248	CcSEcCtD
Chloramphenicol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000484	0.00323	CbGpPWpGaD
Chloramphenicol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000484	0.00323	CbGpPWpGaD
Chloramphenicol—CD55—GPCR ligand binding—CCR5—multiple sclerosis	0.00048	0.00321	CbGpPWpGaD
Chloramphenicol—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000478	0.00319	CbGpPWpGaD
Chloramphenicol—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000478	0.00319	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—S1PR1—multiple sclerosis	0.000476	0.00318	CbGpPWpGaD
Chloramphenicol—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000476	0.00242	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000476	0.00242	CcSEcCtD
Chloramphenicol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000475	0.00242	CcSEcCtD
Chloramphenicol—Feeling abnormal—Prednisolone—multiple sclerosis	0.00047	0.00239	CcSEcCtD
Chloramphenicol—Shock—Betamethasone—multiple sclerosis	0.000468	0.00238	CcSEcCtD
Chloramphenicol—Shock—Dexamethasone—multiple sclerosis	0.000468	0.00238	CcSEcCtD
Chloramphenicol—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000466	0.00238	CcSEcCtD
Chloramphenicol—Nervous system disorder—Betamethasone—multiple sclerosis	0.000466	0.00238	CcSEcCtD
Chloramphenicol—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000466	0.00237	CcSEcCtD
Chloramphenicol—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000466	0.00237	CcSEcCtD
Chloramphenicol—CD55—Immune System—NOD1—multiple sclerosis	0.000465	0.00311	CbGpPWpGaD
Chloramphenicol—Angioedema—Prednisone—multiple sclerosis	0.000464	0.00236	CcSEcCtD
Chloramphenicol—CD55—Signaling Pathways—GPC5—multiple sclerosis	0.000463	0.00309	CbGpPWpGaD
Chloramphenicol—Eye disorder—Methotrexate—multiple sclerosis	0.000455	0.00232	CcSEcCtD
Chloramphenicol—Urticaria—Prednisolone—multiple sclerosis	0.000453	0.00231	CcSEcCtD
Chloramphenicol—CD55—Immune System—MALT1—multiple sclerosis	0.000449	0.003	CbGpPWpGaD
Chloramphenicol—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.000448	0.00299	CbGpPWpGaD
Chloramphenicol—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000448	0.00299	CbGpPWpGaD
Chloramphenicol—Pain—Triamcinolone—multiple sclerosis	0.000448	0.00228	CcSEcCtD
Chloramphenicol—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000442	0.00295	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000442	0.00295	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—IRF5—multiple sclerosis	0.000442	0.00295	CbGpPWpGaD
Chloramphenicol—Vomiting—Mitoxantrone—multiple sclerosis	0.000442	0.00225	CcSEcCtD
Chloramphenicol—Immune system disorder—Methotrexate—multiple sclerosis	0.00044	0.00224	CcSEcCtD
Chloramphenicol—Rash—Mitoxantrone—multiple sclerosis	0.000438	0.00223	CcSEcCtD
Chloramphenicol—Dermatitis—Mitoxantrone—multiple sclerosis	0.000438	0.00223	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—CD86—multiple sclerosis	0.000436	0.00291	CbGpPWpGaD
Chloramphenicol—Headache—Mitoxantrone—multiple sclerosis	0.000435	0.00222	CcSEcCtD
Chloramphenicol—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000435	0.0029	CbGpPWpGaD
Chloramphenicol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000434	0.0029	CbGpPWpGaD
Chloramphenicol—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000432	0.0022	CcSEcCtD
Chloramphenicol—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000431	0.0022	CcSEcCtD
Chloramphenicol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000429	0.00219	CcSEcCtD
Chloramphenicol—CD55—Signaling by GPCR—CCL3—multiple sclerosis	0.000423	0.00282	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—HLA-G—multiple sclerosis	0.000423	0.00282	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—IRF8—multiple sclerosis	0.000423	0.00282	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—IFIH1—multiple sclerosis	0.000423	0.00282	CbGpPWpGaD
Chloramphenicol—Hypersensitivity—Prednisolone—multiple sclerosis	0.00042	0.00214	CcSEcCtD
Chloramphenicol—Urticaria—Triamcinolone—multiple sclerosis	0.000416	0.00212	CcSEcCtD
Chloramphenicol—Urticaria—Methylprednisolone—multiple sclerosis	0.000415	0.00212	CcSEcCtD
Chloramphenicol—Body temperature increased—Triamcinolone—multiple sclerosis	0.000414	0.00211	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Prednisone—multiple sclerosis	0.000414	0.00211	CcSEcCtD
Chloramphenicol—Nausea—Mitoxantrone—multiple sclerosis	0.000413	0.0021	CcSEcCtD
Chloramphenicol—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000411	0.00209	CcSEcCtD
Chloramphenicol—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000411	0.00209	CcSEcCtD
Chloramphenicol—Shock—Prednisone—multiple sclerosis	0.000407	0.00208	CcSEcCtD
Chloramphenicol—CD55—Signaling by GPCR—PTGER4—multiple sclerosis	0.000407	0.00272	CbGpPWpGaD
Chloramphenicol—CD55—Innate Immune System—HLA-B—multiple sclerosis	0.000407	0.00272	CbGpPWpGaD
Chloramphenicol—Pain—Betamethasone—multiple sclerosis	0.000407	0.00207	CcSEcCtD
Chloramphenicol—Pain—Dexamethasone—multiple sclerosis	0.000407	0.00207	CcSEcCtD
Chloramphenicol—Nervous system disorder—Prednisone—multiple sclerosis	0.000406	0.00207	CcSEcCtD
Chloramphenicol—CD55—Signaling Pathways—RGS1—multiple sclerosis	0.000404	0.0027	CbGpPWpGaD
Chloramphenicol—Skin disorder—Prednisone—multiple sclerosis	0.000402	0.00205	CcSEcCtD
Chloramphenicol—CD55—Immune System—TNFAIP3—multiple sclerosis	0.000396	0.00264	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—CXCR3—multiple sclerosis	0.000393	0.00263	CbGpPWpGaD
Chloramphenicol—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000392	0.00262	CbGpPWpGaD
Chloramphenicol—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000392	0.00262	CbGpPWpGaD
Chloramphenicol—Feeling abnormal—Betamethasone—multiple sclerosis	0.000392	0.002	CcSEcCtD
Chloramphenicol—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000392	0.002	CcSEcCtD
Chloramphenicol—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000388	0.00259	CbGpPWpGaD
Chloramphenicol—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000388	0.00259	CbGpPWpGaD
Chloramphenicol—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000386	0.00197	CcSEcCtD
Chloramphenicol—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000385	0.00196	CcSEcCtD
Chloramphenicol—CD55—Signaling Pathways—GPR65—multiple sclerosis	0.000383	0.00256	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000383	0.00256	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000383	0.00256	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—CCR2—multiple sclerosis	0.000383	0.00255	CbGpPWpGaD
Chloramphenicol—Leukopenia—Methotrexate—multiple sclerosis	0.00038	0.00193	CcSEcCtD
Chloramphenicol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000378	0.00253	CbGpPWpGaD
Chloramphenicol—Urticaria—Dexamethasone—multiple sclerosis	0.000378	0.00193	CcSEcCtD
Chloramphenicol—Urticaria—Betamethasone—multiple sclerosis	0.000378	0.00193	CcSEcCtD
Chloramphenicol—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000377	0.00252	CbGpPWpGaD
Chloramphenicol—Body temperature increased—Dexamethasone—multiple sclerosis	0.000376	0.00192	CcSEcCtD
Chloramphenicol—Body temperature increased—Betamethasone—multiple sclerosis	0.000376	0.00192	CcSEcCtD
Chloramphenicol—CD55—GPCR ligand binding—POMC—multiple sclerosis	0.000375	0.00251	CbGpPWpGaD
Chloramphenicol—Pruritus—Triamcinolone—multiple sclerosis	0.000371	0.00189	CcSEcCtD
Chloramphenicol—Pruritus—Methylprednisolone—multiple sclerosis	0.00037	0.00189	CcSEcCtD
Chloramphenicol—CD55—GPCR ligand binding—CCL2—multiple sclerosis	0.000367	0.00245	CbGpPWpGaD
Chloramphenicol—Rash—Prednisolone—multiple sclerosis	0.000359	0.00183	CcSEcCtD
Chloramphenicol—Dermatitis—Prednisolone—multiple sclerosis	0.000359	0.00183	CcSEcCtD
Chloramphenicol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000359	0.00183	CcSEcCtD
Chloramphenicol—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000358	0.00182	CcSEcCtD
Chloramphenicol—Headache—Prednisolone—multiple sclerosis	0.000357	0.00182	CcSEcCtD
Chloramphenicol—CD55—Immune System—CD28—multiple sclerosis	0.000356	0.00238	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—CNR1—multiple sclerosis	0.000353	0.00236	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CCR1—multiple sclerosis	0.000351	0.00234	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CXCL13—multiple sclerosis	0.000351	0.00234	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—PTPRC—multiple sclerosis	0.00035	0.00233	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—CCR2—multiple sclerosis	0.00035	0.00233	CbGpPWpGaD
Chloramphenicol—Confusional state—Methotrexate—multiple sclerosis	0.000349	0.00178	CcSEcCtD
Chloramphenicol—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000347	0.00231	CbGpPWpGaD
Chloramphenicol—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000347	0.00231	CbGpPWpGaD
Chloramphenicol—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000346	0.00176	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—TLR4—multiple sclerosis	0.000345	0.0023	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000342	0.00228	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000342	0.00228	CbGpPWpGaD
Chloramphenicol—Feeling abnormal—Prednisone—multiple sclerosis	0.000341	0.00174	CcSEcCtD
Chloramphenicol—Nervous system disorder—Methotrexate—multiple sclerosis	0.000339	0.00173	CcSEcCtD
Chloramphenicol—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000339	0.00173	CcSEcCtD
Chloramphenicol—Nausea—Prednisolone—multiple sclerosis	0.000339	0.00173	CcSEcCtD
Chloramphenicol—CD55—Immune System—HLA-DPB1—multiple sclerosis	0.000338	0.00226	CbGpPWpGaD
Chloramphenicol—Pruritus—Dexamethasone—multiple sclerosis	0.000336	0.00171	CcSEcCtD
Chloramphenicol—Pruritus—Betamethasone—multiple sclerosis	0.000336	0.00171	CcSEcCtD
Chloramphenicol—Skin disorder—Methotrexate—multiple sclerosis	0.000336	0.00171	CcSEcCtD
Chloramphenicol—Vomiting—Triamcinolone—multiple sclerosis	0.000333	0.0017	CcSEcCtD
Chloramphenicol—Vomiting—Methylprednisolone—multiple sclerosis	0.000332	0.00169	CcSEcCtD
Chloramphenicol—Rash—Triamcinolone—multiple sclerosis	0.00033	0.00168	CcSEcCtD
Chloramphenicol—Dermatitis—Triamcinolone—multiple sclerosis	0.00033	0.00168	CcSEcCtD
Chloramphenicol—Rash—Methylprednisolone—multiple sclerosis	0.00033	0.00168	CcSEcCtD
Chloramphenicol—Dermatitis—Methylprednisolone—multiple sclerosis	0.000329	0.00168	CcSEcCtD
Chloramphenicol—Urticaria—Prednisone—multiple sclerosis	0.000329	0.00168	CcSEcCtD
Chloramphenicol—Headache—Triamcinolone—multiple sclerosis	0.000328	0.00167	CcSEcCtD
Chloramphenicol—Headache—Methylprednisolone—multiple sclerosis	0.000328	0.00167	CcSEcCtD
Chloramphenicol—Body temperature increased—Prednisone—multiple sclerosis	0.000327	0.00167	CcSEcCtD
Chloramphenicol—Diarrhoea—Betamethasone—multiple sclerosis	0.000325	0.00166	CcSEcCtD
Chloramphenicol—Diarrhoea—Dexamethasone—multiple sclerosis	0.000325	0.00166	CcSEcCtD
Chloramphenicol—CD55—Immune System—CD40—multiple sclerosis	0.000325	0.00217	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—ITGA4—multiple sclerosis	0.000325	0.00217	CbGpPWpGaD
Chloramphenicol—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000324	0.00216	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—IFNB1—multiple sclerosis	0.000323	0.00215	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—CTLA4—multiple sclerosis	0.00032	0.00214	CbGpPWpGaD
Chloramphenicol—CD55—Innate Immune System—CD80—multiple sclerosis	0.000318	0.00212	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—CXCL10—multiple sclerosis	0.000318	0.00212	CbGpPWpGaD
Chloramphenicol—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000316	0.00211	CbGpPWpGaD
Chloramphenicol—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000316	0.00211	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000312	0.00208	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000312	0.00208	CbGpPWpGaD
Chloramphenicol—Nausea—Triamcinolone—multiple sclerosis	0.000311	0.00159	CcSEcCtD
Chloramphenicol—Nausea—Methylprednisolone—multiple sclerosis	0.000311	0.00158	CcSEcCtD
Chloramphenicol—Hypersensitivity—Prednisone—multiple sclerosis	0.000305	0.00156	CcSEcCtD
Chloramphenicol—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000304	0.00203	CbGpPWpGaD
Chloramphenicol—Vomiting—Dexamethasone—multiple sclerosis	0.000302	0.00154	CcSEcCtD
Chloramphenicol—Vomiting—Betamethasone—multiple sclerosis	0.000302	0.00154	CcSEcCtD
Chloramphenicol—Rash—Dexamethasone—multiple sclerosis	0.0003	0.00153	CcSEcCtD
Chloramphenicol—Rash—Betamethasone—multiple sclerosis	0.0003	0.00153	CcSEcCtD
Chloramphenicol—Dermatitis—Betamethasone—multiple sclerosis	0.0003	0.00153	CcSEcCtD
Chloramphenicol—Dermatitis—Dexamethasone—multiple sclerosis	0.0003	0.00153	CcSEcCtD
Chloramphenicol—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000299	0.00152	CcSEcCtD
Chloramphenicol—Headache—Dexamethasone—multiple sclerosis	0.000298	0.00152	CcSEcCtD
Chloramphenicol—Headache—Betamethasone—multiple sclerosis	0.000298	0.00152	CcSEcCtD
Chloramphenicol—Pain—Methotrexate—multiple sclerosis	0.000296	0.00151	CcSEcCtD
Chloramphenicol—Pruritus—Prednisone—multiple sclerosis	0.000293	0.00149	CcSEcCtD
Chloramphenicol—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000292	0.00195	CbGpPWpGaD
Chloramphenicol—Feeling abnormal—Methotrexate—multiple sclerosis	0.000285	0.00145	CcSEcCtD
Chloramphenicol—Diarrhoea—Prednisone—multiple sclerosis	0.000283	0.00144	CcSEcCtD
Chloramphenicol—CD55—Immune System—VCAM1—multiple sclerosis	0.000283	0.00189	CbGpPWpGaD
Chloramphenicol—Nausea—Dexamethasone—multiple sclerosis	0.000282	0.00144	CcSEcCtD
Chloramphenicol—Nausea—Betamethasone—multiple sclerosis	0.000282	0.00144	CcSEcCtD
Chloramphenicol—CD55—Immune System—HLA-DQA1—multiple sclerosis	0.000282	0.00188	CbGpPWpGaD
Chloramphenicol—Urticaria—Methotrexate—multiple sclerosis	0.000275	0.0014	CcSEcCtD
Chloramphenicol—CD55—Signaling by GPCR—CCL5—multiple sclerosis	0.000274	0.00183	CbGpPWpGaD
Chloramphenicol—Body temperature increased—Methotrexate—multiple sclerosis	0.000274	0.00139	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—TYK2—multiple sclerosis	0.000269	0.00179	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—HLA-DQB1—multiple sclerosis	0.000264	0.00176	CbGpPWpGaD
Chloramphenicol—Vomiting—Prednisone—multiple sclerosis	0.000263	0.00134	CcSEcCtD
Chloramphenicol—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000263	0.00175	CbGpPWpGaD
Chloramphenicol—Rash—Prednisone—multiple sclerosis	0.000261	0.00133	CcSEcCtD
Chloramphenicol—Dermatitis—Prednisone—multiple sclerosis	0.000261	0.00133	CcSEcCtD
Chloramphenicol—Headache—Prednisone—multiple sclerosis	0.000259	0.00132	CcSEcCtD
Chloramphenicol—Hypersensitivity—Methotrexate—multiple sclerosis	0.000255	0.0013	CcSEcCtD
Chloramphenicol—CD55—Immune System—CD86—multiple sclerosis	0.000254	0.0017	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CCL3—multiple sclerosis	0.00025	0.00167	CbGpPWpGaD
Chloramphenicol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000249	0.00167	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—CD40LG—multiple sclerosis	0.000249	0.00166	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—CCR5—multiple sclerosis	0.000247	0.00165	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—CD8A—multiple sclerosis	0.000246	0.00164	CbGpPWpGaD
Chloramphenicol—Nausea—Prednisone—multiple sclerosis	0.000246	0.00125	CcSEcCtD
Chloramphenicol—Pruritus—Methotrexate—multiple sclerosis	0.000245	0.00125	CcSEcCtD
Chloramphenicol—CD55—Signaling by GPCR—IL2RA—multiple sclerosis	0.000243	0.00162	CbGpPWpGaD
Chloramphenicol—CD55—Innate Immune System—CD4—multiple sclerosis	0.000243	0.00162	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—PTGER4—multiple sclerosis	0.000241	0.00161	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—HLA-B—multiple sclerosis	0.000237	0.00158	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—PGR—multiple sclerosis	0.000237	0.00158	CbGpPWpGaD
Chloramphenicol—Diarrhoea—Methotrexate—multiple sclerosis	0.000237	0.00121	CcSEcCtD
Chloramphenicol—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000234	0.00156	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CXCR3—multiple sclerosis	0.000232	0.00155	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CD28—multiple sclerosis	0.00023	0.00154	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CCR2—multiple sclerosis	0.000226	0.00151	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—IL2RA—multiple sclerosis	0.000222	0.00148	CbGpPWpGaD
Chloramphenicol—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000221	0.00148	CbGpPWpGaD
Chloramphenicol—Vomiting—Methotrexate—multiple sclerosis	0.00022	0.00112	CcSEcCtD
Chloramphenicol—CD55—Immune System—HLA-A—multiple sclerosis	0.000219	0.00147	CbGpPWpGaD
Chloramphenicol—Rash—Methotrexate—multiple sclerosis	0.000218	0.00111	CcSEcCtD
Chloramphenicol—Dermatitis—Methotrexate—multiple sclerosis	0.000218	0.00111	CcSEcCtD
Chloramphenicol—Headache—Methotrexate—multiple sclerosis	0.000217	0.00111	CcSEcCtD
Chloramphenicol—CD55—Signaling Pathways—CNR1—multiple sclerosis	0.000209	0.00139	CbGpPWpGaD
Chloramphenicol—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000208	0.00139	CbGpPWpGaD
Chloramphenicol—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000208	0.00139	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000206	0.00137	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000206	0.00137	CbGpPWpGaD
Chloramphenicol—Nausea—Methotrexate—multiple sclerosis	0.000206	0.00105	CcSEcCtD
Chloramphenicol—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000203	0.00135	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—TLR4—multiple sclerosis	0.000201	0.00134	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—HLA-DRB1—multiple sclerosis	0.000201	0.00134	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—POMC—multiple sclerosis	0.000193	0.00129	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—ICAM1—multiple sclerosis	0.000192	0.00128	CbGpPWpGaD
Chloramphenicol—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00019	0.00127	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—CCL2—multiple sclerosis	0.000189	0.00126	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CXCL10—multiple sclerosis	0.000188	0.00125	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—CD80—multiple sclerosis	0.000185	0.00124	CbGpPWpGaD
Chloramphenicol—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000181	0.00121	CbGpPWpGaD
Chloramphenicol—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000175	0.00117	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—TYK2—multiple sclerosis	0.000171	0.00114	CbGpPWpGaD
Chloramphenicol—CD55—Innate Immune System—MAPK1—multiple sclerosis	0.000171	0.00114	CbGpPWpGaD
Chloramphenicol—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000165	0.0011	CbGpPWpGaD
Chloramphenicol—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000164	0.0011	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CD86—multiple sclerosis	0.000164	0.0011	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CCL5—multiple sclerosis	0.000162	0.00108	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—TYK2—multiple sclerosis	0.000156	0.00104	CbGpPWpGaD
Chloramphenicol—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000155	0.00103	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—SRM—multiple sclerosis	0.000151	0.00101	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—SPP1—multiple sclerosis	0.00015	0.000999	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000149	0.000996	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000149	0.000996	CbGpPWpGaD
Chloramphenicol—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000147	0.00098	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—IFNG—multiple sclerosis	0.000146	0.000978	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CCR5—multiple sclerosis	0.000146	0.000972	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—IL2RA—multiple sclerosis	0.000144	0.000958	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—IL2—multiple sclerosis	0.000142	0.000951	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—CD4—multiple sclerosis	0.000141	0.000944	CbGpPWpGaD
Chloramphenicol—CYP3A7—Biological oxidations—POMC—multiple sclerosis	0.00014	0.000932	CbGpPWpGaD
Chloramphenicol—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000134	0.000894	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000133	0.000889	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000133	0.000889	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—APOE—multiple sclerosis	0.000132	0.000884	CbGpPWpGaD
Chloramphenicol—CD55—Innate Immune System—IL6—multiple sclerosis	0.000131	0.000877	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—IL1B—multiple sclerosis	0.000131	0.000872	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—IL2—multiple sclerosis	0.00013	0.000869	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000121	0.00081	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000121	0.00081	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CD80—multiple sclerosis	0.00012	0.0008	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—POMC—multiple sclerosis	0.000114	0.00076	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CCL2—multiple sclerosis	0.000111	0.000743	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—STAT3—multiple sclerosis	0.00011	0.000731	CbGpPWpGaD
Chloramphenicol—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000109	0.000731	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—MAPK1—multiple sclerosis	0.000109	0.000727	CbGpPWpGaD
Chloramphenicol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000109	0.000727	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—SRM—multiple sclerosis	0.000109	0.000727	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	0.000106	0.000708	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	0.000106	0.000708	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—TYK2—multiple sclerosis	0.000101	0.000675	CbGpPWpGaD
Chloramphenicol—CYP3A5—Biological oxidations—POMC—multiple sclerosis	0.000101	0.000673	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—MAPK1—multiple sclerosis	9.95e-05	0.000665	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—GPC5—multiple sclerosis	9.7e-05	0.000648	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—SRM—multiple sclerosis	9.43e-05	0.000629	CbGpPWpGaD
Chloramphenicol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.83e-05	0.000589	CbGpPWpGaD
Chloramphenicol—CYP2C8—Biological oxidations—POMC—multiple sclerosis	8.74e-05	0.000583	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—SRM—multiple sclerosis	8.41e-05	0.000562	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—IL2—multiple sclerosis	8.41e-05	0.000562	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—IL6—multiple sclerosis	8.37e-05	0.000559	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—RRM1—multiple sclerosis	8.04e-05	0.000537	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—MMP9—multiple sclerosis	7.96e-05	0.000532	CbGpPWpGaD
Chloramphenicol—CYP2C19—Biological oxidations—POMC—multiple sclerosis	7.8e-05	0.000521	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—SRM—multiple sclerosis	7.67e-05	0.000512	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	7.67e-05	0.000512	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	7.67e-05	0.000512	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—IL6—multiple sclerosis	7.65e-05	0.000511	CbGpPWpGaD
Chloramphenicol—CYP2C9—Biological oxidations—POMC—multiple sclerosis	7.11e-05	0.000475	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—STAT3—multiple sclerosis	7.08e-05	0.000473	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—GPC5—multiple sclerosis	7.01e-05	0.000468	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	6.64e-05	0.000443	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	6.64e-05	0.000443	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—MYC—multiple sclerosis	6.58e-05	0.000439	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—TGFB1—multiple sclerosis	6.56e-05	0.000438	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.49e-05	0.000433	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—MAPK1—multiple sclerosis	6.44e-05	0.00043	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—GPC5—multiple sclerosis	6.07e-05	0.000406	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	5.93e-05	0.000396	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	5.93e-05	0.000396	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—RRM1—multiple sclerosis	5.81e-05	0.000388	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.79e-05	0.000387	CbGpPWpGaD
Chloramphenicol—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.56e-05	0.000371	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—GPC5—multiple sclerosis	5.42e-05	0.000362	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	5.41e-05	0.000361	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	5.41e-05	0.000361	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.28e-05	0.000353	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—SRM—multiple sclerosis	5.06e-05	0.000338	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—RRM1—multiple sclerosis	5.03e-05	0.000336	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—IL6—multiple sclerosis	4.95e-05	0.00033	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—GPC5—multiple sclerosis	4.94e-05	0.00033	CbGpPWpGaD
Chloramphenicol—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.69e-05	0.000313	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—BCHE—multiple sclerosis	4.62e-05	0.000308	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—RRM1—multiple sclerosis	4.49e-05	0.0003	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—RRM1—multiple sclerosis	4.1e-05	0.000273	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.91e-05	0.000261	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.56e-05	0.000238	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.56e-05	0.000238	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.49e-05	0.000233	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.35e-05	0.000224	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—BCHE—multiple sclerosis	3.34e-05	0.000223	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.26e-05	0.000218	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.18e-05	0.000212	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.06e-05	0.000204	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.99e-05	0.0002	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—BCHE—multiple sclerosis	2.89e-05	0.000193	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—APOE—multiple sclerosis	2.78e-05	0.000185	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.73e-05	0.000182	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.73e-05	0.000182	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.7e-05	0.00018	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.58e-05	0.000172	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.49e-05	0.000166	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—POMC—multiple sclerosis	2.39e-05	0.000159	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.35e-05	0.000157	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—ALB—multiple sclerosis	2.18e-05	0.000145	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—APOE—multiple sclerosis	2.01e-05	0.000134	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—APOE—multiple sclerosis	1.74e-05	0.000116	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—POMC—multiple sclerosis	1.72e-05	0.000115	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—ALB—multiple sclerosis	1.57e-05	0.000105	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—APOE—multiple sclerosis	1.55e-05	0.000104	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.55e-05	0.000104	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—POMC—multiple sclerosis	1.49e-05	9.97e-05	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—APOE—multiple sclerosis	1.42e-05	9.45e-05	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—ALB—multiple sclerosis	1.36e-05	9.09e-05	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—POMC—multiple sclerosis	1.33e-05	8.9e-05	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—POMC—multiple sclerosis	1.22e-05	8.12e-05	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—ALB—multiple sclerosis	1.22e-05	8.12e-05	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—ALB—multiple sclerosis	1.11e-05	7.4e-05	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—APOE—multiple sclerosis	9.34e-06	6.23e-05	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—POMC—multiple sclerosis	8.02e-06	5.35e-05	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—ALB—multiple sclerosis	7.31e-06	4.88e-05	CbGpPWpGaD
